SHUKRA PHARMACEUTICALS
Back to Balance Sheet
|
SHUKRA PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹4.50 Cr | ₹6.65 Cr | ₹6.04 Cr | ₹7.16 Cr | ₹6.39 Cr |
What is the latest Total Non-Current Liabilities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹4.50 Cr |
| Mar2025 | ₹6.65 Cr |
| Mar2024 | ₹6.04 Cr |
| Mar2023 | ₹7.16 Cr |
| Mar2022 | ₹6.39 Cr |
How is Total Non-Current Liabilities of SHUKRA PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.50 Cr | -32.35 | |
| Mar2025 | ₹6.65 Cr | 10.03 | |
| Mar2024 | ₹6.04 Cr | -15.63 | |
| Mar2023 | ₹7.16 Cr | 12.18 | |
| Mar2022 | ₹6.39 Cr | - | |
Compare Total Non-Current Liabilities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹3,165.6 Cr | 4.5% | 28.4% | 79.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 4.5% |
28.4% |
79.6% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses